Home › NDC Lookup › Labelers › Horizon Therapeutics Usa, Inc.

Horizon Therapeutics Usa, Inc. NDCs and Package Codes

This page lists NDC package records associated with labeler code 75987 (Horizon Therapeutics Usa, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

15
Package NDCs
21
Products
21
Active listings
0
Discontinued
7
Ingredients
0
Therapeutic classes
8
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
Cysteamine bitartrate 8
pegloticase 6
sodium phenylbutyrate 2
teprotumumab 2
glycerol phenylbutyrate 1
Interferon gamma-1b 1
Inebilizumab 1
By dosage form
INJECTION, SOLUTION 7
CAPSULE, DELAYED RELEASE PELLETS 4
GRANULE, DELAYED RELEASE 4
INJECTION, POWDER, LYOPHILIZED, FO... 2
LIQUID 1
TABLET 1
POWDER 1
INJECTION 1

Browse records — 21 products

Drug / product Billing NDC NADAC / unit Status
ACTIMMUNE Interferon gamma-1b 100 ug/.5mL INJECTION, SOLUTION Horizon · NDC 75987-0111-11 · 12 VIAL, SINGLE-USE in 1 CARTON (75987-111-11) / .5 mL in 1 VIAL, SINGLE-USE (75987-111-10) 75987-0111-11 — On market View →
BUPHENYL sodium phenylbutyrate 500 mg/1 TABLET Horizon · NDC 75987-0060-08 · 1 BOTTLE in 1 CARTON (75987-060-08) / 250 TABLET in 1 BOTTLE 75987-0060-08 — On market View →
Buphenyl sodium phenylbutyrate .94 g/g POWDER Horizon · NDC 75987-0070-09 · 1 BOTTLE in 1 CARTON (75987-070-09) / 250 g in 1 BOTTLE 75987-0070-09 — On market View →
Krystexxa pegloticase 8 mg/mL INJECTION, SOLUTION Horizon · NDC 75987-0080-10 · J2507 · 1 VIAL in 1 CARTON (75987-080-10) / 1 mL in 1 VIAL 75987-0080-10 — On market View →
Krystexxa pegloticase 8 mg/50mL INJECTION, SOLUTION Horizon · NDC 75987-0058-01 · J2507 · 1 VIAL in 1 CARTON (75987-058-01) / 50 mL in 1 VIAL 75987-0058-01 — On market View →
Krystexxa pegloticase 8 mg/50mL INJECTION, SOLUTION Horizon · NDC 75987-0058-01 · J2507 · 1 VIAL in 1 CARTON (75987-058-01) / 50 mL in 1 VIAL 75987-0058-01 — On market View →
Krystexxa pegloticase 8 mg/mL INJECTION, SOLUTION Horizon · NDC 75987-0080-10 · J2507 · 1 VIAL in 1 CARTON (75987-080-10) / 1 mL in 1 VIAL 75987-0080-10 — On market View →
Krystexxa pegloticase 8 mg/mL INJECTION, SOLUTION Horizon · NDC 75987-0080-10 · J2507 · 1 VIAL in 1 CARTON (75987-080-10) / 1 mL in 1 VIAL 75987-0080-10 — On market View →
Krystexxa pegloticase 8 mg/50mL INJECTION, SOLUTION Horizon · NDC 75987-0058-01 · J2507 · 1 VIAL in 1 CARTON (75987-058-01) / 50 mL in 1 VIAL 75987-0058-01 — On market View →
PROCYSBI Cysteamine bitartrate 25 mg/1 CAPSULE, DELAYED RELEASE PELLETS Horizon · NDC 75987-0100-04 · 60 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (75987-100-04) 75987-0100-04 — On market View →
PROCYSBI Cysteamine bitartrate 75 mg/1 CAPSULE, DELAYED RELEASE PELLETS Horizon · NDC 75987-0101-08 · 250 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (75987-101-08) 75987-0101-08 — On market View →
PROCYSBI Cysteamine bitartrate 75 mg/1 GRANULE, DELAYED RELEASE Horizon · NDC 75987-0140-13 · 60 PACKET in 1 CARTON (75987-140-13) / 1 GRANULE, DELAYED RELEASE in 1 PACKET 75987-0140-13 — On market View →
PROCYSBI Cysteamine bitartrate 300 mg/1 GRANULE, DELAYED RELEASE Horizon · NDC 75987-0145-13 · 60 PACKET in 1 CARTON (75987-145-13) / 1 GRANULE, DELAYED RELEASE in 1 PACKET 75987-0145-13 — On market View →
PROCYSBI Cysteamine bitartrate 300 mg/1 GRANULE, DELAYED RELEASE Horizon · NDC 75987-0145-13 · 60 PACKET in 1 CARTON (75987-145-13) / 1 GRANULE, DELAYED RELEASE in 1 PACKET 75987-0145-13 — On market View →
PROCYSBI Cysteamine bitartrate 75 mg/1 GRANULE, DELAYED RELEASE Horizon · NDC 75987-0140-13 · 60 PACKET in 1 CARTON (75987-140-13) / 1 GRANULE, DELAYED RELEASE in 1 PACKET 75987-0140-13 — On market View →
PROCYSBI Cysteamine bitartrate 25 mg/1 CAPSULE, DELAYED RELEASE PELLETS Horizon · NDC 75987-0100-04 · 60 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (75987-100-04) 75987-0100-04 — On market View →
PROCYSBI Cysteamine bitartrate 75 mg/1 CAPSULE, DELAYED RELEASE PELLETS Horizon · NDC 75987-0101-08 · 250 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (75987-101-08) 75987-0101-08 — On market View →
Ravicti glycerol phenylbutyrate 1.1 g/mL LIQUID Horizon · NDC 75987-0050-06 · 1 BOTTLE in 1 CARTON (75987-050-06) / 25 mL in 1 BOTTLE 75987-0050-06 — On market View →
TEPEZZA teprotumumab 500 mg/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Horizon · NDC 75987-0130-15 · J3241 · 1 VIAL, SINGLE-DOSE in 1 CARTON (75987-130-15) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE 75987-0130-15 — On market View →
TEPEZZA teprotumumab 500 mg/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Horizon · NDC 75987-0130-15 · J3241 · 1 VIAL, SINGLE-DOSE in 1 CARTON (75987-130-15) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE 75987-0130-15 — On market View →
UPLIZNA Inebilizumab 10 mg/mL INJECTION Horizon · NDC 75987-0150-03 · J1823 · 3 VIAL, SINGLE-DOSE in 1 CARTON (75987-150-03) / 10 mL in 1 VIAL, SINGLE-DOSE (75987-150-01) 75987-0150-03 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.